|
Market Closed -
Nasdaq
04:00:00 2026-10-23 pm EDT
|
5-day change | 1st Jan Change | ||
| 64.53 USD | -1.19% |
|
+3.70% | +47.23% |
| Oct. 09 | Exelixis' Zanzalintinib Clinical Trials for Cancer Highly Likely to Succeed, RBC Says | MT |
| Oct. 09 | RBC Raises Price Target on Exelixis to $51 From $45, Keeps Sector Perform Rating | MT |
| Market Cap | 15.99B 14.27B 13.18B 11.96B 22.39B 1,518B 22.73B 159B 62.78B 794B 59.99B 58.72B 2,507B | P/E 2026 * |
19.8x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 15.24B 13.61B 12.56B 11.4B 21.35B 1,447B 21.68B 151B 59.85B 757B 57.2B 55.99B 2,391B | EV / Sales 2026 * |
5.97x | EV / Sales 2027 * | 4.95x |
| Free-Float |
98.15% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| EXEL | Delayed | |
CBOE
| EXEL | Real-time | |
|
Börse Stuttgart
| EX9 | Delayed | |
|
Borsa Italiana
| 1EXEL | End-of-day quote | |
|
Berne S.E.
| EX9 | End-of-day quote | |
|
Tradegate
| EX9 | Real-time | |
|
Boerse Muenchen
| EX9 | Real-time | |
|
Deutsche Boerse AG
| EX9 | Delayed |
Last Transcript: Exelixis, Inc.
| 1 day | -1.19% | ||
| 1 week | +3.70% | ||
| Current month | +10.48% | ||
| 1 month | +13.75% | ||
| 3 months | +15.96% | ||
| 6 months | +40.13% | ||
| Current year | +47.23% |
| 1 week | 61.67 |  | 65.5 |
| 1 month | 57.02 | | 65.5 |
| Current year | 39.71 | | 65.5 |
| 1 year | 36 | | 65.5 |
| 3 years | 19.12 | | 65.5 |
| 5 years | 14.87 | | 65.5 |
| 10 years | 10.04 | | 65.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2010-07-21 | |
| Director of Finance/CFO | 58 | 2015-07-14 | |
Dana Aftab
COO | Chief Operating Officer | 63 | 2016-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 2004-01-31 | |
George Poste
BRD | Director/Board Member | 82 | 2004-07-31 |
| Chairman | 77 | 1997-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/10/26 | Sell | Director | -9,812 | 0.0039% | ||
| 6/1/26 | Sell | Director | -9,812 | 0.0039% | ||
| 6/1/26 | Sell | Director | -3,925 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.19% | +3.70% | +69.59% | +235.22% | 15.99B | |
| +2.41% | +0.29% | +42.02% | +71.57% | 64.69B | |
| -0.15% | +7.50% | +11.01% | +73.48% | 54.78B | |
| +0.57% | +4.60% | +10.07% | +92.86% | 53.49B | |
| +0.37% | +4.67% | +27.03% | +52.07% | 45.98B | |
| -1.21% | +2.32% | +21.80% | +123.81% | 42.94B | |
| -0.37% | +5.07% | +249.91% | +918.74% | 40.08B | |
| +0.05% | +0.21% | +18.26% | +58.53% | 33.52B | |
| -0.38% | +5.68% | +36.43% | +27.54% | 23.67B | |
| +1.19% | -4.98% | +29.01% | -0.65% | 23.97B | |
| Average | +0.13% | +2.57% | +51.51% | +165.32% | 39.91B | |
| Weighted average by Cap. | +0.33% | +2.78% | +48.45% | +161.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.55B 2.28B 2.1B 1.91B 3.58B 243B 3.63B 25.35B 10.03B 127B 9.58B 9.38B 401B | 2.9B 2.59B 2.39B 2.17B 4.06B 276B 4.13B 28.8B 11.39B 144B 10.89B 10.66B 455B |
| Net income | 820M 732M 676M 614M 1.15B 77.89B 1.17B 8.14B 3.22B 40.76B 3.08B 3.01B 129B | 1B 895M 826M 750M 1.4B 95.16B 1.43B 9.95B 3.94B 49.81B 3.76B 3.68B 157B |
| Net Debt | -744M -665M -614M -557M -1.04B -70.68B -1.06B -7.39B -2.92B -36.99B -2.79B -2.73B -117B | -1.62B -1.45B -1.34B -1.21B -2.27B -154B -2.31B -16.1B -6.37B -80.63B -6.09B -5.96B -254B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | $64.53 | -1.19% | 2,066,169 |
| 26-10-22 | $65.31 | +1.13% | 1,710,332 |
| 26-10-21 | $64.58 | +0.30% | 1,494,337 |
| 26-10-20 | $64.39 | +2.73% | 2,136,862 |
| 26-10-19 | $62.68 | +0.72% | 1,934,214 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EXEL Stock
Select your edition
All financial news and data tailored to specific country editions
